Product Description
Anti-ITGB2 (Rovelizumab) -SMCC-DM1 ADC | ADC-W-1502 | Creative Biolabs
Short Description: This ADC product is comprised of an anti-ITGB2 monoclonal antibody conjugated via a SMCC linker to DM1
Status: In stock
Expected Delivery Time: 9-11Weeks